GeneScience Pharmaceuticals Co. Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
- Investments
-
1
GeneScience Pharmaceuticals Co. General Information
Description
Manufacturer of biopharmaceutical drugs based in Changchun, China. The company offers a range of products including somatropin injections, molgramostim gel, filgramostim injection and recombinant human follitropin injection.
Contact Information
Website
www.gensci-china.com(Operating Subsidiary)
Corporate Office
- 72 Tianhe Street
- Changchun High-Tech Dev. Zone
- Changchun, Jilin
- China
Corporate Office
- 72 Tianhe Street
- Changchun High-Tech Dev. Zone
- Changchun, Jilin
- China
GeneScience Pharmaceuticals Co. Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
GeneScience Pharmaceuticals Co. Patents
GeneScience Pharmaceuticals Co. Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1941901-A1 | An exterior-applied formulation and its preparation methods and uses | Active | 27-Sep-2005 | ||
| EP-1941901-A4 | An exterior-applied formulation and its preparation methods and uses | Active | 27-Sep-2005 | ||
| EP-1941901-B1 | An exterior-applied formulation and its preparation methods and uses | Inactive | 27-Sep-2005 | ||
| WO-2007036107-A1 | An exterior-applied formulation and its preparation methods and uses | Inactive | 27-Sep-2005 | ||
| US-20090156482-A1 | External preparation containing recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carrier; corneal lesions and corneal ulcers | Active | 27-Sep-2005 | A61K9/0048 |
GeneScience Pharmaceuticals Co. Investments (1)
GeneScience Pharmaceuticals Co.’s most recent deal was a Later Stage VC with Rani Therapeutics for . The deal was made on 22-Dec-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rani Therapeutics | 22-Dec-2017 | Later Stage VC | Drug Delivery |
GeneScience Pharmaceuticals Co. Exits (1)
GeneScience Pharmaceuticals Co.’s most recent exit was on 22-Dec-2017 from Rani Therapeutics. The exit was categorized as with 15 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Rani Therapeutics | 22-Dec-2017 | Completed |
|
GeneScience Pharmaceuticals Co. FAQs
-
When was GeneScience Pharmaceuticals Co. founded?
GeneScience Pharmaceuticals Co. was founded in 1996.
-
Where is GeneScience Pharmaceuticals Co. headquartered?
GeneScience Pharmaceuticals Co. is headquartered in Changchun, China.
-
What industry is GeneScience Pharmaceuticals Co. in?
GeneScience Pharmaceuticals Co.’s primary industry is Pharmaceuticals.
-
Is GeneScience Pharmaceuticals Co. a private or public company?
GeneScience Pharmaceuticals Co. is a Private company.
-
What is GeneScience Pharmaceuticals Co.’s current revenue?
The current revenue for GeneScience Pharmaceuticals Co. is .
-
When was GeneScience Pharmaceuticals Co. acquired?
GeneScience Pharmaceuticals Co. was acquired on 06-Jun-2019.
-
Who acquired GeneScience Pharmaceuticals Co.?
GeneScience Pharmaceuticals Co. was acquired by Changchun High and New Technology Industries Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
